International and national guidelines (S3 guideline) for the surveillance of post-treatment breast cancer patients recommend a clinical follow-up including routine history and physical examination and regular mammograms. The practice of a clinical follow-up has been often discussed, but has been proven...
General: Recommendations for Lobular Carcinoma in Situ (LCIS-1) were removed from the NCCN Guidelines for Breast Cancer; see the NCCN Guidelines for Breast Cancer Screening and Diagnosis. 导管原位癌的诊断、检查、基本治疗(DCIS-1) 修改:若患者遗传性乳腺癌风险高则进行遗传咨询 → 若患者有遗传性乳腺癌...
Breast cancer stands as the most frequently diagnosed cancer and the primary cause of cancer-related mortality among women worldwide, including Italy. With the increasing number of survivors, many are enrolled in regular follow-up programs. However, adherence to recommendations from scientific societies...
Results The results have demonstrated the different follow-up protocols currently indicated in these guidelines within the same country. Furthermore, the lack of well designed, randomised controlled trials on which to base a follow-up protocol for patients with breast cancer is apparent. Conclusion ...
There are no changes in the guidelines that cite different treatment in the case of the follow-up of inflammatory breast cancer (IBC) and locally advanced breast cancer. Thus, treatment should adhere to the already established guidelines for locally advanced cancer of metastatic cancer of the breas...
Once they have achieved their treatments, patients should undergo careful follow-up. It aims at detecting early local recurrence or controlateral breast cancer. Based on large cohorts, clinical and radiological follow-up procedures come from guidelines realised by scientific organisations. We evaluated ...
The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up: a randomized screening trial of mammography in... Miller,Anthony,B.,... - ...
The existing follow-up standard for breast cancer patients has been reviewed by a representative trial involving 1,004 curatively treated patients, who underwent surgery between 1977 and 1987. The objective of the study has been to establish whether intensive diagnostics of recurrences and metastases ...
For non-gBRCA mutated triple-negative advanced breast cancer, there is currently no evidence to support the use of specific treatment regimens, and the chemotherapy regimens can follow what is recommend for HER2-negative breast cancer. Platinum-based therapy is important for TNBC, especially for tho...
Breast cancer is the most common malignancy in women, affecting thousands of people each year. The majority of women are diagnosed with early stage breast cancer, which is curable. The follow-up care of the breast cancer survivor requires an understanding of the goals of follow-up and the sho...